Erisyon is currently preparing to introduce the instrument in the near future. Erisyon is currently open to discuss early access as well as potential collaborations.
Erisyon has emerged from the University of Texas at Austin to commercialize the world’s first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT’s Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.
VP of Software Development & Cofounder
VP of Product Development & Cofounder
CEO & Cofounder